Age (years) (mean ± SD) |
44,6 ± 6,2 |
56,7 ± 11,6 |
58 ± 11,5 |
P < 0.05 versus CTRL |
Age (years) (median ± IQR) |
44 (34–54) |
56 (32–75) |
57 (30–79) |
P < 0.05 versus CTRL |
Male, n (%) |
17 (57) |
18 (60) |
30 (60) |
P = NS |
Hypertension, n (%) |
7 (23) |
17 (57) |
30 (60) |
P < 0.05 versus CTRL |
Hypercholesterolaemia, n (%) |
8 (26) |
23 (77) |
35 (70) |
P < 0.05 versus CTRL |
Type 2 diabetes mellitus, n (%) |
0 |
11 (36) |
18 (36) |
P < 0.05 versus CTRL |
Smoking, n (%) |
12 (40) |
19 (63) |
32 (64) |
P < 0.05 versus CTRL |
Family history of IHD, n (%) |
8 (27) |
13 (43) |
24 (48) |
P < 0.05 versus CTRL |
Statins prior to hospitalization, n (%) |
0 |
20 (67) |
32 (64) |
P < 0.05 versus CTRL |
ACE inhibitors, n (%) |
4 (13) |
16 (53) |
23 (46) |
P < 0.05 versus CTRL |
Acetylsalicylic acid, n (%) |
2 (7) |
28 (100) |
31 (62) |
P < 0.05 versus CTRL, SAP |
Total cholesterol [mg/dL] |
199 (156–256) |
201 (156–256) |
201,5 (122–313) |
P = NS |
HDL cholesterol [mg/dL] |
43 (20–70) |
43 (24–75) |
41 (13–74) |
P = NS |
LDL Cholesterol [mg/dL] |
97 (89–124) |
100 (65–216) |
105 (65–113) |
P = NS |
Triglycerides [mg/dL] |
150 (123–200) |
176,5 (84–269) |
163 (76–375) |
P = NS |
Creatinine [mg/dL] |
0,9 (0,7–1,4) |
0,9 (0,8–1,3) |
0,9 (0,7–14) |
P = NS |
Erythrocytes [×106/μL] |
4,7 (4,2–5,1) |
4,7 (4,3–5,1) |
4,62 (4,12–5,2) |
P = NS |
Leucocytes [×103/μL] |
6,9 (5,5–8,3) |
6,6 (5,2–7,4) |
10,17 ± 2,8 |
P < 0.001 versus CTRL, SAP |
Monocytes [×103/μL] |
0,8 (0,4–1,2) |
0,7 (0,46–1,14) |
0,76 (0,41–1,1) |
P = NS |
Platelets [×103/μL] |
195 (143–246) |
194 (137–251) |
198 (146–250) |
P = NS |
|
Initial LVEF ≤40%, n (%) |
— |
— |
14 (28) |
|
Initial CKMB [U/l] |
— |
— |
26,5 (5–136) |
|
Initial TnI [ng/mL] |
— |
— |
0,7 (0,0–18) |
|
Maximal CKMB [U/l] |
— |
— |
109,5 (5–572) |
|
Maximal TnI [ng/mL] |
— |
— |
4,7 (0,92–72) |
|
Anterior wall infarction, n (%) |
— |
— |
30 (60) |
|
Multivessel CAD, n (%) |
— |
— |
26 (52) |
|